abstract |
The invention relates to peptide derivatives and peptidomimetic agents as transglutaminase inhibitors. The invention also relates to methods for the production of said compounds, to pharmaceutical compositions containing the same, and to uses of the transglutaminase inhibitors, especially for treating coeliac disease and other transglutaminase-dependent diseases. |